This video demonstrates how intraoperative optical coherence tomography (iOCT) can assist in the implantation and optimal placement of 2 trabecular bypass minimally invasive glaucoma surgery (MIGS) devices: the iStent inject W and the Hydrus microstent.

Dr. Lorraine Provencher moderates this journal club with Dr. Russell N. Van Gelder discussing a Mendelian randomization study on habitual coffee consumption increases risk of primary open-angle glaucoma.

In this presentation, Dr. Jost B. Jonas covers the clinical assessment of the optic nerve head.

In this presentation from Glaucoma Subspecialty Day 2021, an expert panel details a range of surgical challenges.

In this journal club and late-breaking session at Glaucoma Subspecialty Day 2021, experts discuss the sustained-release bimatoprost implant, as well as surgical approach and other topics.

In this session from Glaucoma Subspecialty Day 2021, American Glaucoma Society lecturer Dr. Michele C. Lim provides information on the use of mitomycin C in traditional and novel glaucoma surgeries.

In this presentation from Glaucoma Subspecialty Day 2021, experts provide information on the use of optical coherence tomography (OCT) and visual field testing.

In the present video, four distinct surgeries are showcased, with each video involving more and more deeper sclera planes.

The patient is a 85-year-old man with bilateral primary open-angle glaucoma.

In this webinar, Drs. Chen, Junk, Fleischman and Bhorade provide updates on the management of glaucoma. Topics include an update on Hydrus, a summary of the ZAP trial, and lifestyle modifications for glaucoma patients.

This video shows the mostly commonly used techniques, as well as intraoperative complications that may occur during the performance.

Dr. Gross gives an overview of the course titled "Examining the Optic Nerve and Examining the Visual Field: The Five Rs." The purpose of this course is to provide a systematic toolkit to help the ophthalmologist better evaluate the structure and function of glaucoma, to aid…

In this presentation, Dr. Arsham Sheybani discusses cataract surgery in the glaucoma patient with mild to moderate open-angle glaucoma. He shares a case of a 73-year-old myopic man whose left eye was 20/25 with a pressure of 13 on 3 classes and 2+ NS, and he presents informa…

Dr. Peter Andreas Netland demonstrates how treatment of neovascular glaucoma depends upon the etiology, the stage of the disease, the visual potential, and other individual patient factors.

Dr. Janet Serle discusses the newest IOP-lowering glaucoma medications, including latanoprostene bunod or LBN, netarsudil, fixed-dose combination netarsudil/latanoprost, and the bimatoprost implant.

Dr. Jacob Brubaker discusses continuous wave and micropulse technologies, particularly transscleral diode cyclophotocoagulation, and considerations for their use in view of a glaucoma patient's medical and surgical history.

In this video, Dr. Sunita Radhakrishnan discusses the ZAP and EAGLE trials regarding the use of iridotomy for primary angle closure.

In this video, Dr. Van Tassel discusses the issue of patients with moderate glaucoma, nonadherence to topical medications, and failed selective laser trabeculoplasty (SLT), and explains why she recommends sustained-release therapy as the next step.

Dr. Lola Idowu reviews outcomes from the PIVOTAL trial, which evaluated the safety and effectiveness of the iStent Inject, an ab interno implanted trabecular micro-bypass system, in combination with cataract surgery.

Dr. Jeremy Jones leads a discussion of the study "Macular versus nerve fibre layer versus optic nerve head imaging for diagnosing glaucoma at different stages of the disease: Multicenter Italian Glaucoma Imaging Study."

The visual field (VF) is prone to all sorts of variability and artifacts, and it can show defects caused by diseases other than glaucoma. It's important to systematically and carefully evaluate each field, especially any that look not classic for retinal nerve fiber layer de…

In this video, Dr. Angelo Tanna discusses what medication to add for a patient who needs a second medication to control intraocular pressure (IOP). He shares findings from a meta-analysis of randomized clinical trials assessing the IOP-lowering efficacy of alpha 2 adrenergic…

Dr. Nathan Radcliffe discusses use of selective laser trabeculoplasty (SLT) on the patient using a single glaucoma medication with intraocular pressure (IOP) above the target level. He refers to the LIGHT trial, which compares SLT and eye drops for first-line treatment of oc…

In this presentation, Dr. Andrew Chen describes why he would recommend surgery for the glaucoma patient with moderate glaucoma with nonadherence to topical medications and with failed selective laser trabeculoplasty (SLT).

In this AAO 2020 presentation, "Management of Ocular Emergencies in the Elderly: UK vs. US," Dr. Anthony Khawaja presents the UK perspective on treating emergent cases of acute angle-closure attack in the elderly.